Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Heart failure with normal ejection fraction is often under diagnosed and certainly under
treated in hemodialyzed patients. Because of the benefit of reducing heart rate, ivabradine,
a pure heart-rate lowering agent without effects on blood pressure, is of potential
therapeutic utility.
Phase:
Phase 4
Details
Lead Sponsor:
Second University of Naples University of Campania "Luigi Vanvitelli"